MissionIR Articles
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at the H.C. Wainwright BioConnect 2021 Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its CEO, John Climaco, will present…
-
Sustainable Green Team Ltd. (SGTM) Stands to Benefit as US Lumber Prices Soar to Record Highs
Strong growth in US lumber demand has led to both record price increases – and record levels of timber, tree debris along with it Sustainable Green Team has sought to introduce environmentally sustainable solution to…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) Releases Report on Patent Filings, Therapeutics Program Development
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, has provided an update on its patent filings. The company has eight filings, all tied to Cybin’s novel therapeutics, delivery mechanisms and treatment…
-
MissionIRNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics Completes QM CoRE(TM) Integration
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its wholly owned subsidiary Helomics has completed the integration of Quantitative Medicine’s (“QM”)…
-
MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Releases Powerful SaaS Platform Called iSCRM
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, has launched a powerful off-the-shelf (standard) SaaS enterprise management platform. Called iSCRM, the platform is designed for daily operations and social customer…
-
MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Regains Full Compliance with Nasdaq Listing Requirements
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced its receipt of notice from The Nasdaq Stock Market on Jan. 5, 2021,…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) to Participate in H.C. Wainwright BioConnect Virtual Conference
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that it will participate in the virtual H.C. Wainwright BioConnect Conference taking place on Jan. 11-14,…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at Upcoming H.C. Wainwright Bioconnect Conference
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced…
-
Cybin Inc. (NEO: CYBN) R&D Sees Hope in Growing Acceptance of Psilocybin
U.S. taking actionable steps toward acceptance of psilocybin States, individual cities have decriminalized, made use and possession of psilocybin low law-enforcement priority More psilocybin research being done focused on health, well-being of Americans facing a…
-
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Finalizes Chemours Monazite Supply Agreement, Marks Beginning of ‘Real Success Story’
UUUU to receive minimum of 2,500 tons of natural monazite ore, one of highest-grade REE minerals in world Company to produce raw materials needed for clean energy, advanced technologies while also creating green jobs in…
-
MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) Engages Investor Relations Firm
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that it has hired an investor relations firm. POAI has chosen Landon Capital to…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters into Agreement with Fortune 500 Subsidiary to Provide Digital Therapeutics Solution
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has been selected by a subsidiary of a U.S.-based Fortune 500 technology and engineering company to provide its digital therapeutics solution to eligible employees.…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in LifeSci Partners Corporate Access Event
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, will be participating in the 10th annual LifeSci Partners Corporate Access Event. As part of the company’s participation, AzurRx president and CEO…
-
Knightscope Introduces App to Help Identify Locations Where Autonomous Public Safety Robots Can Protect and Serve
Autonomous Security Robot (ASR) developer Knightscope has deployed its high-tech sentries at institutions including hospitals, universities, Fortune 1000 companies and even on behalf of NBA team the Sacramento Kings Knightscope counts law enforcement personnel and…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Shares Objectives for Berubicin Phase 2 Trial
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently hosted a webinar to discuss the clinical design…
-
MissionIRNewsBreaks – Knightscope Inc. Deploys K5 ASR Solution for Phoenix-Based Shopping Center
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its entry into another contract in Arizona. According to NRF, organized retail crime (“ORC”) costs the retail industry approximately…
-
CNS Pharmaceuticals (NASDAQ: CNSP) Conducts Public Offering Funding Effort, Appears in Syndicated Broadcast on Brain Cancer Drug Advances
Neuro-oncology drug developer CNS Pharmaceuticals is completing an underwritten public offering of common stock shares and warrants in a bid to fund its upcoming Phase 2 trials for a candidate in fighting glioblastoma brain cancers…
-
MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Strategic Board Appointment, Continued Drive of Integrated Data-Driven Solutions
iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced the addition of Philip Kan to its board of directors, effective Jan. 1, 2021. Per the…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Issues Development Update on Its Operating Subsidiary, Xunpusen
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced that its subsidiary, Xunpusen Technology Co. Ltd.,…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Appointment of Digital Media Veteran as CEO of BIGtoken
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through its software-as-a-service (“SaaS”) platform, Sequire, today announced that Lou Kerner will be appointed chief executive officer of its…
Search Articles
Latest Articles
- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) at the Crossroads of National Security and Critical Mineral Supply
- Brera Holdings PLC’s (NASDAQ: BREA) Juve Stabia Stadium to Host Italy’s First Serie A Women’s Cup Semifinals
- MissionIRNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Initiated at Outperform by Noble Capital with $20 Price Target
- West Vault Mining Inc. (TSX.V: WVM) (OTCQX: WVMDF) Is ‘One to Watch’
- MissionIRNewsBreaks – Red Cat Holdings, Inc. (NASDAQ: RCAT) Collaborates with Safe Pro Group (NASDAQ: SPAI) to Integrate AI Threat Detection into Black Widow Drones